Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytogenetic changes in prostatic carcinoma]

G Sauter1, L Bubendorf, H Moch

  • 1Institut für Pathologie, Universitätsspital Basel.

Der Pathologe
|June 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer.

ESMO gastrointestinal oncology·2026
Same author

Advancing Lung Cancer Staging: Integrating IASLC Recommendations and Bioinformatics to Delineate Tumor Origins.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

From wind to seismic signature captured by seismometers in lake Lucerne.

Scientific reports·2025
Same author

Unravelling lung adenocarcinoma with mucinous histology and its translational implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.

ESMO open·2023
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Genetic alterations in prostate cancer, including deletions and gains on specific chromosomes, are linked to tumor development. Identifying these genes could improve treatment strategies for this common cancer.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Context:

  • Prostate cancer is a frequent malignancy with incompletely understood genetic underpinnings.
  • Tumorigenesis is driven by genetic malfunctions, necessitating the identification of key genes in prostate cancer.

Purpose:

  • To review current knowledge on genetic alterations in prostate cancer.
  • To highlight chromosomal regions frequently affected by deletions and gains in prostate tumors.
  • To discuss the clinical relevance of identified genetic changes.

Summary:

  • Cytogenetic and molecular analyses reveal frequent chromosomal deletions at 7q, 8p, 10q, 13q, 16q, 17p, and the Y chromosome, potentially harboring tumor suppressor genes.
  • Recurrent DNA copy number gains are observed on chromosomes 7, 8q, and 11q, suggesting the presence of novel oncogenes.

Related Experiment Videos

  • Specific genetic alterations, such as polysomies and androgen receptor amplification, correlate with poor prognosis and treatment resistance in prostate cancer.

    • Impact:

    • Understanding these genetic alterations provides insights into prostate cancer development and progression.
    • Identification of specific genes involved in prostate cancer can pave the way for targeted therapies.
    • This knowledge is crucial for developing improved diagnostic and prognostic tools for prostate cancer patients.